Flupentixol is a typical antipsychotic medication belonging to the thioxanthene class, primarily used to treat schizophrenia and other psychotic disorders. It works by blocking dopamine receptors in the brain, helping to reduce symptoms such as hallucinations, delusions, and agitation. Developed in the 1960s, flupentixol was introduced as part of the effort to create effective antipsychotics with fewer sedative effects compared to earlier drugs like chlorpromazine. Over time, it has been used in both short-term treatment of acute psychosis and long-term maintenance therapy, sometimes combined with psychotherapy, marking a significant advancement in psychiatric care.